Pellegrin, Isabelle <br/><br/>
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.  [electronic resource] 

 -  Journal of medical virology  Oct 2005 
 - 164-72 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0146-6615 
<br/><br/><label>Standard No.: </label>10.1002/jmv.20452  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active<br/>CD4 Lymphocyte Count<br/>DNA, Viral--blood<br/>Drug Administration Schedule<br/>Drug Resistance, Multiple, Viral<br/>Female<br/>Genotype<br/>HIV Infections--blood<br/>HIV-1--drug effects<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Middle Aged<br/>Mutation<br/>RNA, Viral--blood<br/>Viral Load